24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Stem Cell Industry, October 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, cancer, more »


 
1-10 of about 200 reports for Stem Cell

Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., Ltd.

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

... Ltd. There is a textual review of the financial results of shanghai jiaoda onlly co., Ltd. Versus zhongyuan union stem cell bio-engineering corp, zhenxing biopharmaceutical & chemical inc and jiangsu ...

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Marrow, caco-2, cancer stem cells, cardiomyocytes, cho cells, chondrocytes, cord blood stem cells, cornea, corneal epithelial cells, dendritic cells, dental pulp stem cells, dermal papilla cells ...

BrainStorm Cell Therapeutics Inc. (Symbol:BCLI) SWOT Analysis, Strategy, Revenues and Profits

BrainStorm Cell Therapeutics Inc. (Symbol:BCLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Develops autologous stem cell therapies for debilitating neurodegenerative diseases, such as amyotrophic lateral sclerosis, multiple sclerosis and parkinson's disease. It develops nurown technology ...

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... S products include stem cells, parthenogenesis, and therapeutic programs. Iscc provides stem cells such as embryonic stem cells, induced pluripotent stem cells, adult stem cells and parthenogenetic stem cells ...

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... For the treatment cdad prophylaxis in hematopoietic stem cell transplantation (hsct) patients, cdad in pediatric patients, and cdad multiple recurrence; and dificlir and fidaxomicin for the treatment of clostridium ...

Vitro Diagnostics, Inc. (Symbol:VODG) SWOT Analysis, Strategy, Revenues and Profits

Vitro Diagnostics, Inc. (Symbol:VODG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... The company offers cell culture media under the brand name, msc-gro. It also provides basic tools to support stem cell research and clinical studies of mscs. The company partners with neuromics, hemo ...

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... cells (dpscs) and hematopoietic stem cells (hscs). Mesoblast serves various therapeutic areas such as immunologic/ inflammatory, cardiac vascular, spine disease, ophthalmolog, neurologic and oncology ...

StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Disclaimer note*: some sections may be missing if data is unavailable for the company list of tables stemcells, inc., Key information stemcells, inc ...

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Matrix-511 worldwide for robust proliferation of human stem cellsjun 17, 2013: clontech labs and takara bio announce availability of retronectin reagent to support gene therapy clinical research ...

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Tigenix nv (tig) - financial and strategic swot analysis review summarytigenix nv (tigenix) is a pharmaceutical company. The company provides clinical stage pipeline of adult stem cell ...

About 1 200 reports for Stem Cell

Download Unlimited Documents from Trusted Public Sources

Stem Cell Industry in Russia

  • The Social Legitimation of Biomedical Technologies in Russia: Co...
  • January 2013
    21 pages
  • Stem Cell  

  • Russian Federat...  

View report >

Annual Report, 2014

January 2014

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.